Hosted on MSN1mon
Sanofi gets FDA approval for NovoLog insulin biosimilarSanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog ... mL single-patient-use prefilled pen and 10 mL multiple-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results